Physician initiated, prospective, non-randomized multicenter trial, investigating the safety and efficacy of the Treatment with the Luminor DCB and the iVolution pro stent of iVascular in TASC C and D femoropopliteal atherosclerotic disease.
DESCRIPTION
Device
Luminor 18, Luminor 35 and iVolution pro
Number of patients
100
Follow up
5 years
Type of lesions
Long femoropopliteal lesions TASC C&D
OUTCOMES
Primary Patency (1 year)1
Freedom from TLR (5 years)2
1- LINC 2020 by Dr Koen Deloose.
2- LINC 2025 by Dr Koen Deloose.
CONCLUSIONS
MAIN INVESTIGATOR
In conclusion, Dr. Koen Deloose stated that “the combined use of Luminor and iVolution pro seems to be, in the longer run, the perfect solution for complex lesion treatment”.
Dr. Koen Deloose, A.Z.
Sint-Blasius Hospital (Dendermonde, BE)
